Zenas BioPharma, Inc. Common Stock (ZBIO) stock news · rev $10.0M
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
This ZBIO news page leads with what Zenas BioPharma, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for ZBIO yet. We will not pad this page with generic market recap.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ZBIO stock page; for the tape open the quote page.
ZBIO stock news FAQ
What are ZBIO's latest revenue and net income?
Latest cached Zenas BioPharma, Inc. Common Stock (ZBIO) revenue for Dec 31, 2025 was $10.0M. Net income was -$377.7M. Statements: https://lician.com/financials/zbio
How did ZBIO revenue change from the prior cached period?
Cached Zenas BioPharma, Inc. Common Stock (ZBIO) revenue was up 100.0% from $5.0M (Dec 31, 2024) to $10.0M (Dec 31, 2025). Statements: https://lician.com/financials/zbio
What is ZBIO's market cap?
Zenas BioPharma, Inc. Common Stock (ZBIO) market cap is $798.0M on the latest cached fundamentals snapshot.
What kind of company is ZBIO?
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Where is ZBIO stock news listed?
Cached stock news for Zenas BioPharma, Inc. Common Stock (ZBIO) is listed at https://lician.com/news/zbio. Filings: https://lician.com/sec/zbio
Not investment advice.